Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001641172-25-006421·Opaleye Management Inc.
Schedule 13G ownership disclosure
Protara Therapeutics Inc
Common Stock · CUSIP: 74365U107
Event date: 2025-03-31
- Filing-level shares
- 1,730,000.00
- Percent of class
- 4.71%
- Opaleye Management, Inc.
Shares: 1,730,000.00 · Class: 4.71%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-006421
- Form type
- SCHEDULE 13G/A
- Filer
- Opaleye Management Inc.
- CIK
- CIK 1595855
- Filed
- Apr 28, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership